RF32 | PSUN59 Glucagon-Like Peptide-1 Analogues: A New Way to Quit Smoking? SKIP – a Randomised Controlled Study

BACKGROUND: Cigarette smoking is the leading preventable cause of premature death. Despite dedicated programs, quit rates remain low due to barriers such as nicotine withdrawal syndrome or post-cessation weight gain. Glucagon-like peptide-1 (GLP-1) analogues reduce energy intake and body weight and...

Descripción completa

Detalles Bibliográficos
Autores principales: Atila, Cihan, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Sailer, Clara, Coynel, David, Vogt, Deborah R, Hemkens, Lars G, Speich, Benjamin, Kühne, Jill, Baur, Fabienne, Lutz, Linda, Davide, Zanchi, Christ-Crain, Mirjam, Winzeler, Bettina, Lengsfeld, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625035/
http://dx.doi.org/10.1210/jendso/bvac150.536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625035/
http://dx.doi.org/10.1210/jendso/bvac150.536

Ejemplares similares